Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-07-28

FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

FDA approved a generic combination tablet of bisoprolol fumarate and hydrochlorothiazide for hypertension, manufactured by Unichem Pharmaceuticals (USA), Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol Fumarate and Hydrochlorothiazide (bisoprolol fumarate and hydrochlorothiazide)

Snippet

ORIG AP for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE)